Why you should care about the bond market right now
Summary
Marketplace host Kimberly Adams discusses the global bond market with Capital Economics’ Bradley Saunders, who analyzes the Treasury’s bond buyback efforts amid rising US debt and investor concerns. The episode then shifts to the psychedelic medicine industry, featuring Josh Hardman of Psychedelic Alpha. They explore Eli Lilly’s acquisition of Atai Life Sciences, the legal landscape for drugs like psilocybin and MDMA, and the shift toward major pharmaceutical involvement in developing these therapies for mental health.
Topics discussed
Odoo: All-in-one business software ad
Bond market jitters and US Treasury intervention
Optum: Improving healthcare connectivity ad
VantageScore: Modern credit scoring ad
Psychedelics in mental health: Legal and business landscape
Marketplace listener survey and closing
Listen ad-free on Castria